文献速递主动脉外科

四分支人工血管联合顺行脑灌注行全主动脉弓置换术:1005例15年经验

Total arch replacement using a 4-branched graft with antegrade cerebral perfusion.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-10-17

该研究回顾了2001年5月起15年内1005例采用四分支人工血管联合顺行脑灌注行全主动脉弓置换术的患者,其中252例为急诊手术。住院死亡率为5.2%,永久性神经功能障碍率3.6%,5年生存率80.7%,10年生存率63.1%。结论认为该技术可获得可接受的短期和长期结果。

要点

  • 四分支人工血管联合顺行脑灌注行全弓置换住院死亡率5.2%。
  • 永久性神经功能障碍率3.6%,暂时性神经功能障碍率6.4%。
  • 5年生存率80.7%,10年生存率63.1%,无脊髓并发症。

核心结论

  • 采用四分支人工血管联合顺行脑灌注行全主动脉弓置换术可获得可接受的短期和长期结果。

研究设计与样本

  • 回顾性单中心病例系列,2001年5月至研究截止共纳入1005例接受全主动脉弓置换术的患者,平均年龄69.8±11.2岁(范围9-92岁),男性744例,其中252例为急性主动脉夹层或动脉瘤破裂的急诊手术。

主要发现

  • 手术时间482±171分钟,体外循环时间254±94分钟,心脏缺血时间145±51分钟,顺行脑灌注时间160±47分钟,下半身循环停止时间62±16分钟。
  • 住院死亡率5.2%,永久性神经功能障碍率3.6%,暂时性神经功能障碍率6.4%,无脊髓并发症。
  • 5年生存率80.7%,10年生存率63.1%。
  • 15例(1.5%)因弓部人工血管假性动脉瘤(11例)、溶血(3例)和感染(1例)再次手术。

临床怎么用

  • 对于需行全主动脉弓置换的患者,可考虑采用四分支人工血管联合顺行脑灌注技术,该技术在本大样本中显示可接受的死亡率和神经并发症率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Total arch replacement (TAR) is an established standard surgical procedure. We report >1000 cases of TAR using a 4-branched graft with antegrade cerebral perfusion (ACP) during a 15-year period. METHODS: Since May 2001, 1005 patients who underwent total aortic replacement (mean age 69.8 ± 11.2 years; range, 9-92 years; 744 male) underwent TAR with a 4-branched graft. All surgeries were performed under hypothermia with ACP. There were 252 emergent operations for acute aortic dissection or aneurysm rupture. Concomitant operations included coronary arterial bypass grafting in 196 patients, aortic valve repair or replacement in 64, and aortic root replacements in 38. RESULTS: The operation time was 482 ± 171 minutes, cardiopulmonary time was 254 ± 94 minutes, cardiac ischemia time was 145 ± 51 minutes, ACP time was 160 ± 47 minutes, and lower body circulatory arrest time was 62 ± 16 minutes. The hospital mortality rate was 5.2%. The permanent neurological dysfunction rate was 3.6% and temporary neurological dysfunction rate was 6.4%. There were no spinal cord complications. The 5-year survival rate was 80.7% and 10-year survival rate was 63.1%. Fifteen patients (1.5%) underwent reoperation for the arch grafts because of a pseudoaneurysm (11 patients), hemolysis (3 patients), and infection (1 patient). CONCLUSIONS: TAR using a 4-branched graft with ACP could be accomplished with acceptable short- and long-term results.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Minatoya K, Inoue Y, Sasaki H, et al. Total arch replacement using a 4-branched graft with antegrade cerebral perfusion. J Thorac Cardiovasc Surg. 2018. PMID: 30527779. doi:10.1016/j.jtcvs.2018.09.112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。